Positron Emission Tomography/Computed Tomography

The Current Technology and Applications

Erik Mittra, Andrew Quon

Research output: Contribution to journalReview article

48 Citations (Scopus)

Abstract

Positron emission tomography (PET) and combined PET/CT provide powerful metabolic and anatomical information together in a single exam. This article reviews the fundamentals of PET physics, the state of the art and future directions in PET technology, and the current clinical applications of PET. The latter is quite diverse and includes oncology, cardiology, neurology, and infection and inflammation imaging, all with FDG as the tracer. Additionally, novel radiopharmeuticals are under development, many of which are target cellular processes that are more specific than glucose metabolism.

Original languageEnglish (US)
Pages (from-to)147-160
Number of pages14
JournalRadiologic Clinics of North America
Volume47
Issue number1
DOIs
StatePublished - Jan 1 2009
Externally publishedYes

Fingerprint

Positron-Emission Tomography
Technology
Physics
Neurology
Cardiology
Positron Emission Tomography Computed Tomography
Inflammation
Glucose
Infection

Keywords

  • Cardiology
  • Fluorodeoxyglucose
  • Infection and inflammation
  • Neurology
  • Novel radiopharmaceuticals
  • Oncology
  • Physics
  • Positron emission tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Positron Emission Tomography/Computed Tomography : The Current Technology and Applications. / Mittra, Erik; Quon, Andrew.

In: Radiologic Clinics of North America, Vol. 47, No. 1, 01.01.2009, p. 147-160.

Research output: Contribution to journalReview article

@article{dbc6d517fa0a4681bdcc59c9dec0c6c5,
title = "Positron Emission Tomography/Computed Tomography: The Current Technology and Applications",
abstract = "Positron emission tomography (PET) and combined PET/CT provide powerful metabolic and anatomical information together in a single exam. This article reviews the fundamentals of PET physics, the state of the art and future directions in PET technology, and the current clinical applications of PET. The latter is quite diverse and includes oncology, cardiology, neurology, and infection and inflammation imaging, all with FDG as the tracer. Additionally, novel radiopharmeuticals are under development, many of which are target cellular processes that are more specific than glucose metabolism.",
keywords = "Cardiology, Fluorodeoxyglucose, Infection and inflammation, Neurology, Novel radiopharmaceuticals, Oncology, Physics, Positron emission tomography",
author = "Erik Mittra and Andrew Quon",
year = "2009",
month = "1",
day = "1",
doi = "10.1016/j.rcl.2008.10.005",
language = "English (US)",
volume = "47",
pages = "147--160",
journal = "Radiologic Clinics of North America",
issn = "0033-8389",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Positron Emission Tomography/Computed Tomography

T2 - The Current Technology and Applications

AU - Mittra, Erik

AU - Quon, Andrew

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Positron emission tomography (PET) and combined PET/CT provide powerful metabolic and anatomical information together in a single exam. This article reviews the fundamentals of PET physics, the state of the art and future directions in PET technology, and the current clinical applications of PET. The latter is quite diverse and includes oncology, cardiology, neurology, and infection and inflammation imaging, all with FDG as the tracer. Additionally, novel radiopharmeuticals are under development, many of which are target cellular processes that are more specific than glucose metabolism.

AB - Positron emission tomography (PET) and combined PET/CT provide powerful metabolic and anatomical information together in a single exam. This article reviews the fundamentals of PET physics, the state of the art and future directions in PET technology, and the current clinical applications of PET. The latter is quite diverse and includes oncology, cardiology, neurology, and infection and inflammation imaging, all with FDG as the tracer. Additionally, novel radiopharmeuticals are under development, many of which are target cellular processes that are more specific than glucose metabolism.

KW - Cardiology

KW - Fluorodeoxyglucose

KW - Infection and inflammation

KW - Neurology

KW - Novel radiopharmaceuticals

KW - Oncology

KW - Physics

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=58949090833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58949090833&partnerID=8YFLogxK

U2 - 10.1016/j.rcl.2008.10.005

DO - 10.1016/j.rcl.2008.10.005

M3 - Review article

VL - 47

SP - 147

EP - 160

JO - Radiologic Clinics of North America

JF - Radiologic Clinics of North America

SN - 0033-8389

IS - 1

ER -